Home > News > Nanosphere’s gene analyzer soars through first testing round
April 22nd, 2004
Nanosphere’s gene analyzer soars through first testing round
Abstract:
The early reviews on Nanosphere, Inc.'s nanoparticle-based gene detection technology are beginning to come in. And it looks like the technology could be a hit with the lucrative clinical lab market, according to its first group of testers. The Northbrook, Ill.-company launched its Verigene tabletop analyzer for the research market last June. The analyzer is based on core technology that involves coating gold nanoparticles with strings of nucleotides that complement a given genetic target.
Source:
SmallTimes
Bookmark:
Nanomedicine
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
MU Researchers Develop Radioactive Nanoparticles that Target Cancer Cells: This is an early step toward developing therapies for metastasized cancers, MU scientist says May 21st, 2013
Profiles
Russia’s Nano-enabled Products Market to Witness Massive Growth February 8th, 2011
Adept Technology Announces Orders for Over $600K from Chinese Partner January 18th, 2011
Nanostart-held ItN Nanovation Receives Major Follow-on Order in Saudi Arabia November 29th, 2010
Homegrown Companies Developing Batteries for Clean Energy Storage November 2nd, 2010